Cargando…

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease

BACKGROUND: Rapidly progressive forms of Alzheimer’s disease (rpAD) are increasingly recognized and may have a prevalence of up to 30% of patients among all patients with Alzheimer’s disease (AD). However, insights about risk factors, underlying pathophysiological processes, and clinical characteris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herden, Janne Marieke, Hermann, Peter, Schmidt, Isabel, Dittmar, Kathrin, Canaslan, Sezgi, Weglage, Luise, Nuhn, Sabine, Volpers, Corinna, Schlung, Astrid, Goebel, Stefan, Kück, Fabian, Villar-Piqué, Anna, Schmidt, Christian, Wedekind, Dirk, Zerr, Inga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249304/ https://www.ncbi.nlm.nih.gov/pubmed/37291640 http://dx.doi.org/10.1186/s13195-023-01249-y

Ejemplares similares

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
por: Canaslan, Sezgi, et al.
Publicado: (2021)

Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer’s Disease
por: Hermann, Peter, et al.
Publicado: (2022)

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer’s Disease
por: Podlesniy, Petar, et al.
Publicado: (2020)

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
por: Llorens, Franc, et al.
Publicado: (2020)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
por: Schmitz, Matthias, et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers in Alzheimer’s disease, vascular dementia and ischemic stroke patients: a critical analysis
por: Kaerst, Lisa, et al.
Publicado: (2013)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
por: Emdina, Anna, et al.
Publicado: (2022)

Rapidly progressive dementias — aetiologies, diagnosis and management
por: Hermann, Peter, et al.
Publicado: (2022)

Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer’s disease and multiple sclerosis
por: Stoeck, Katharina, et al.
Publicado: (2014)

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
por: Kruse, Niels, et al.
Publicado: (2018)

Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
por: Zerr, Inga, et al.
Publicado: (2019)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers
por: Hermann, Peter, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
por: Llorens, Franc, et al.
Publicado: (2017)

Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia
por: Karch, André, et al.
Publicado: (2013)

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
por: Stoeck, Katharina, et al.
Publicado: (2012)

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis
por: Zerr, Inga, et al.
Publicado: (2020)

Rapid lymphatic efflux limits cerebrospinal fluid flow to the brain
por: Ma, Qiaoli, et al.
Publicado: (2018)

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2019)

Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response
por: Heim, Denise, et al.
Publicado: (2016)

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
por: Schmitz, Matthias, et al.
Publicado: (2022)

Rapid diagnosis of experimental meningitis by bacterial heat production in cerebrospinal fluid
por: Trampuz, Andrej, et al.
Publicado: (2007)

Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
por: Kakuda, Keita, et al.
Publicado: (2019)

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease
por: Zerr, Inga, et al.
Publicado: (2021)

Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer’s Disease
por: Noor, Aneeqa, et al.
Publicado: (2021)

Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients
por: Schmitz, Matthias, et al.
Publicado: (2016)

SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease
por: Younas, Neelam, et al.
Publicado: (2020)

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
por: Shafiq, Mohsin, et al.
Publicado: (2021)

Rapid amplification of prions from variant Creutzfeldt–Jakob disease cerebrospinal fluid
por: Barria, Marcelo A, et al.
Publicado: (2018)

Lupus erythematosus and lichen planus overlap syndrome:a case report with a rapid response to topical corticosteroid therapy
por: Demirci, Gulsen Tukenmez, et al.
Publicado: (2011)

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
por: Candelise, Niccolo, et al.
Publicado: (2020)

Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection
por: Schiedner, Gudrun, et al.
Publicado: (2008)

Specific PCR Assay for Rapid and Direct Detection of Neisseria meningitidis in Cerebrospinal Fluid Specimens
por: Qurbanalizadegan, M, et al.
Publicado: (2010)

On-Chip Cell Staining and Counting Platform for the Rapid Detection of Blood Cells in Cerebrospinal Fluid
por: Lee, Yujin, et al.
Publicado: (2018)

Rapid-Onset Temporal Encephalitis With Negative Cerebrospinal Fluid Polymerase Chain Reaction Testing
por: Phrathep, Davong D, et al.
Publicado: (2023)

CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease
por: Hermann, Peter, et al.
Publicado: (2014)

Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
por: Garcia-Esparcia, Paula, et al.
Publicado: (2017)

Multicenter Testing of the Rapid Quantification of Radical Oxygen Species in Cerebrospinal Fluid to Diagnose Bacterial Meningitis
por: Lukaszewicz, Anne-Claire, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_587t3pct9p4qp37qt86cqu9fbj